{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:59:49Z","timestamp":1783393189807,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ajur.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T01:30:47Z","timestamp":1497403847000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Pathophysiology of clinical benign prostatic hyperplasia"],"prefix":"10.1016","volume":"4","author":[{"given":"Keong Tatt","family":"Foo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2017.06.003_bib1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","article-title":"EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"67","author":"Gratzke","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.11622\/smedj.2013168","article-title":"Diagnosis of prostate adenoma and the relationship of its site to bladder outlet obstruction","volume":"54","author":"Luo","year":"2013","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ajur.2017.06.003_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/iju.13285","article-title":"From evidence-based medicine to evidence-balanced medicine for individualized and personalized care: as applied to benign prostatic hyperplasia\/male lower urinary tract symptoms","volume":"24","author":"Foo","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","article-title":"Normal histology of the prostate","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajur.2017.06.003_bib5","series-title":"Surgical pathology of prostatic obstruction","author":"Randall","year":"1931"},{"key":"10.1016\/j.ajur.2017.06.003_bib6","first-page":"57","article-title":"Significant decrease of extracellular matrix in prostatic urethra of patients with benign prostatic hyperplasia","volume":"29","author":"Babinski","year":"2014","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.ajur.2017.06.003_bib7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2003.04688.x","article-title":"Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate","volume":"93","author":"Cardoso","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2017.06.003_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1442-2042.2002.00453.x","article-title":"Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume","volume":"9","author":"Yuen","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib9","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1097\/01.ju.0000095474.86981.00","article-title":"Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention","volume":"170","author":"Tan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1442-2042.2010.02533.x","article-title":"Re: intravesical prostatic protrusion (IPP) and uroflowmetry in the management of benign prostatic enlargement (BPE)","volume":"17","author":"Foo","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib11","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.juro.2012.09.081","article-title":"Urodynamic studies in adults: AUA\/SUFU guideline","volume":"188","author":"Winters","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1464-410X.2003.04088.x","article-title":"Correlation of intravesical prostatic protrusion with bladder outlet obstruction","volume":"91","author":"Chia","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2017.06.003_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1442-2042.2009.02409.x","article-title":"Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment","volume":"17","author":"Lee","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000224867","article-title":"Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasis","volume":"83","author":"Tiong","year":"2009","journal-title":"Urol Int"},{"key":"10.1016\/j.ajur.2017.06.003_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.juro.2007.03.116","article-title":"Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study","volume":"178","author":"Mariappan","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.47102\/annals-acadmedsg.V44N2p60","article-title":"Relationships between prostatic volume and intravesical prostatic protrusion on transabdominal ultrasound and benign prostatic obstruction in patients with lower urinary tract symptoms","volume":"44","author":"Wang","year":"2015","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.ajur.2017.06.003_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.urology.2012.12.007","article-title":"Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin","volume":"81","author":"Cumpanas","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2017.06.003_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0090-4295(00)01021-9","article-title":"Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin","volume":"57","author":"McNeill","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2017.06.003_bib19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0022-5347(01)66153-6","article-title":"Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction","volume":"155","author":"Rosier","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/(SICI)1520-6777(1996)15:5<447::AID-NAU2>3.0.CO;2-F","article-title":"Lack of correlation of the American urological association symptom 7 index with urodynamic bladder outlet obstruction","volume":"15","author":"Sirls","year":"1996","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2017.06.003_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1464-410X.1995.tb07421.x","article-title":"The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume","volume":"75","author":"Bosch","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005392-200101000-00008","article-title":"The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part 1: when statistics fail","volume":"165","author":"Wadie","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib23","first-page":"648","article-title":"Current assessment and proposed staging of patients with benign prostatic hyperplasia","volume":"24","author":"Foo","year":"1995","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.ajur.2017.06.003_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.47102\/annals-acadmedsg.V39N10p798","article-title":"Staging of benign prostate hyperplasia is helpful in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia","volume":"39","author":"Wang","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.ajur.2017.06.003_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1464-410X.1981.tb03273.x","article-title":"The natural history of untreated \u201cprostatism\u201d","volume":"53","author":"Ball","year":"1981","journal-title":"Br J Urol"},{"key":"10.1016\/j.ajur.2017.06.003_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388217300541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388217300541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:29:54Z","timestamp":1762000194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388217300541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2214388217300541"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2017.06.003","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of clinical benign prostatic hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}